+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030- Product Image
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030- Product Image
New

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • September 2024
  • Region: Global
  • Grand View Research
  • ID: 6009890
Description Jump to:
The global CRISPR-based gene editing market size is anticipated to reach USD 9.14 billion by 2030 and is projected to grow at a CAGR of 14.73% from 2024 to 2030. This robust growth trajectory in the market is driven by several key factors, including the rising prevalence of genetic disorders, significant advancements in CRISPR technology, supportive regulatory frameworks, and increasing investments in biotechnology and healthcare research. Together, these elements create a dynamic environment for innovation and development.

Advancements in CRISPR technology have notably fueled market expansion. Researchers have made remarkable progress in developing more precise and efficient CRISPR systems, including CRISPR/Cas9, CRISPR/Cas12, and emerging base editing technologies. These innovations have broadened the scope of potential applications, extending from treating genetic disorders to formulating targeted therapies for various cancers and infectious diseases. The enhanced ability to edit genes with high specificity and minimal off-target effects has captured considerable interest from both pharmaceutical and biotechnology sectors, which are increasingly eager to leverage these groundbreaking technologies for therapeutic development.

Moreover, the growing emphasis on personalized medicine is significantly influencing the demand for CRISPR technologies. As the healthcare landscape shifts toward more individualized treatment approaches, the capability to edit genes with precision enables the creation of therapies tailored to the unique genetic profiles of patients. This paradigm shift in medicine is likely to further accelerate the adoption of CRISPR technologies, as they provide unparalleled opportunities to develop targeted and effective treatments that can dramatically improve patient outcomes.

Supportive regulatory frameworks are fostering a conducive environment for research and commercialization. Regulatory bodies are increasingly recognizing the potential of CRISPR technologies, leading to streamlined approval processes that encourage innovation. Overall, the confluence of these factors positions the market for continued growth and innovation in the coming years, paving the way for revolutionary advancements in healthcare and biotechnology.

CRISPR-based Gene Editing Market Report Highlights

  • The products segment, which includes CRISPR kits and reagents, CRISPR libraries, and other related tools, led the market with the largest revenue share of 73.96% in 2023
  • Based on application, the biomedical segment led the market with the largest revenue share of 81.83% in 2023 and is also projected to witness at the fastest CAGR of 15.09% during the forecast period. This growth is fueled by several key drivers, including the increasing prevalence of genetic disorders and cancers, alongside significant advancements in CRISPR technology
  • Based on end use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 46.31% in 2023

The leading players in the CRISPR-based Gene Editing market include:

  • Revvity, Inc.
  • Danaher
  • GenScript
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Tocris Bioscience
  • OriGene Technologies, Inc.
  • Bio-Rad Laboratories
  • Bio-Techne
  • New England Biolabs, Inc.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Application Segment
1.2.3. End-use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of genetic disorders
3.2.1.2. Growing investments in biotechnology and healthcare research
3.2.1.3. Advancements in CRISPR technology and applications
3.2.2. Market restraint analysis
3.2.2.1. Ethical concerns surrounding gene editing
3.2.2.2. High costs associated with CRISPR research and development
3.3. CRISPR-based Gene Editing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Products
4.4.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. CRISPR Kits & Reagents
4.4.2.1. CRISPR kits & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. CRISPR Libraries
4.4.3.1. CRISPR libraries market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Services
4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Biomedical
5.4.1. Biomedical market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Therapeutic Development
5.4.2.1. Therapeutic development market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.2. By Indication
5.4.2.2.1. Genetic Disorders
5.4.2.2.1.1. Genetic Disorders market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.2.2. Oncology
5.4.2.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.2.3. Ophthalmology
5.4.2.2.3.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.2.4. Others
5.4.2.2.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.3. By Delivery Method
5.4.2.3.1. Ex Vivo
5.4.2.3.2. Ex vivo market estimates and forecasts, 2018 to 2030 (USD Million
5.4.2.3.3. In Vivo
5.4.2.3.4. In vivo market estimates and forecasts, 2018 to 2030 (USD Million
5.4.3. Disease Diagnostics
5.4.3.1. Disease diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Agricultural applications
5.5.1. Agricultural applications market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.2. Plant Engineering
5.5.2.1. Plant engineering market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.3. Farm Animals Engineering
5.5.3.1. Farm animals engineering market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. CRISPR-based Gene Editing Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global CRISPR-based Gene Editing Market End-use Movement Analysis
6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Contract Research Organizations
6.6.1. Contract research organizations market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Target disease prevalence
7.4.2.4. Regulatory framework
7.4.2.5. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Target disease prevalence
7.4.3.4. Regulatory framework
7.4.3.5. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Target disease prevalence
7.4.4.4. Regulatory framework
7.4.4.5. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Target disease prevalence
7.5.2.4. Regulatory framework
7.5.2.5. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Target disease prevalence
7.5.3.4. Regulatory framework
7.5.3.5. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Target disease prevalence
7.5.4.4. Regulatory framework
7.5.4.5. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Target disease prevalence
7.5.5.4. Regulatory framework
7.5.5.5. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Target disease prevalence
7.5.6.4. Regulatory framework
7.5.6.5. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Target disease prevalence
7.5.7.4. Regulatory framework
7.5.7.5. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Target disease prevalence
7.5.8.4. Regulatory framework
7.5.8.5. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Target disease prevalence
7.5.9.4. Regulatory framework
7.5.9.5. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Target disease prevalence
7.6.2.4. Regulatory framework
7.6.2.5. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Target disease prevalence
7.6.3.4. Regulatory framework
7.6.3.5. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Target disease prevalence
7.6.4.4. Regulatory framework
7.6.4.5. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Target disease prevalence
7.6.5.4. Regulatory framework
7.6.5.5. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Target disease prevalence
7.6.6.4. Regulatory framework
7.6.6.5. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Target disease prevalence
7.6.7.4. Regulatory framework
7.6.7.5. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Target disease prevalence
7.7.2.4. Regulatory framework
7.7.2.5. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Target disease prevalence
7.7.3.4. Regulatory framework
7.7.3.5. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Target disease prevalence
7.8.2.4. Regulatory framework
7.8.2.5. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Target disease prevalence
7.8.3.4. Regulatory framework
7.8.3.5. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Target disease prevalence
7.8.4.4. Regulatory framework
7.8.4.5. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Target disease prevalence
7.8.5.4. Regulatory framework
7.8.5.5. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. List of Key Buyers for CRISPR-based Gene Editing Products & Services
8.5. Company Profiles/Listing
8.5.1. Revvity, Inc.
8.5.1.1. Company overview
8.5.1.2. Financial performance
8.5.1.3. Product/Service benchmarking
8.5.1.4. Strategic initiatives
8.5.2. Danaher Corporation
8.5.2.1. Company overview
8.5.2.2. Financial performance
8.5.2.3. Product/Service benchmarking
8.5.2.4. Strategic initiatives
8.5.3. GenScript
8.5.3.1. Company overview
8.5.3.2. Financial performance
8.5.3.3. Product/Service benchmarking
8.5.3.4. Strategic initiatives
8.5.4. Merck KGaA
8.5.4.1. Company overview
8.5.4.2. Financial performance
8.5.4.3. Product/Service benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Thermo Fisher Scientific, Inc.
8.5.5.1. Company overview
8.5.5.2. Financial performance
8.5.5.3. Product/Service benchmarking
8.5.5.4. Strategic initiatives
8.5.6. Tocris Bioscience
8.5.6.1. Company overview
8.5.6.2. Financial performance
8.5.6.3. Product/Service benchmarking
8.5.6.4. Strategic initiatives
8.5.7. OriGene Technologies, Inc.
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product/Service benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Bio-Rad Laboratories
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product/Service benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Bio-Techne
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product/Service benchmarking
8.5.9.4. Strategic initiatives
8.5.10. New England Biolabs, Inc.
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product/Service benchmarking
8.5.10.4. Strategic initiatives
List of Tables
Table 1. List of abbreviation
Table 2. Global CRISPR-based gene editing market, by region, 2018 - 2030 (USD Million)
Table 3. Global CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 4. Global CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 5. Global CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 6. North America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
Table 7. North America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 8. North America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 9. North America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 10. U.S. CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 11. U.S. CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 12. U.S. CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 13. Canada CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 14. Canada CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 15. Canada CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 16. Mexico CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 17. Mexico CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 18. Mexico CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 19. Europe CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
Table 20. Europe CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 21. Europe CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 22. Europe CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 23. UK CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 24. UK CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 25. UK CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 26. Germany CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 27. Germany CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 28. Germany CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 29. France CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 30. France CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 31. France CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 32. Italy CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 33. Italy CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 34. Italy CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 35. Spain CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 36. Spain CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 37. Spain CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 38. Denmark CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 39. Denmark CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 40. Denmark CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 41. Sweden CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 42. Sweden CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 43. Sweden CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 44. Norway CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 45. Norway CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 46. Norway CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 49. Asia Pacific CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 50. Asia Pacific CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 51. Japan CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 52. Japan CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 53. Japan CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 54. China CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 55. China CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 56. China CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 57. India CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 58. India CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 59. India CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 60. Australia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 61. Australia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 62. Australia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 63. South Korea CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 64. South Korea CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 65. South Korea CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 66. Thailand CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 67. Thailand CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 68. Thailand CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 69. Latin America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
Table 70. Latin America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 71. Latin America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 72. Latin America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 73. Brazil CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 74. Brazil CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 75. Brazil CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 76. Argentina CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 77. Argentina CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 78. Argentina CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 79. MEA CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
Table 80. MEA CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 81. MEA CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 82. MEA CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 83. South Africa CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 84. South Africa CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 85. South Africa CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 89. UAE CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 90. UAE CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 91. UAE CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
Table 92. Kuwait CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
Table 93. Kuwait CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
Table 94. Kuwait CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 CRISPR-based Gene Editing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 CRISPR-based Gene editing market: Product & service outlook key takeaways
Fig. 20 CRISPR-based Gene editing market: Product & service movement analysis
Fig. 21 Products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 CRISPR kits & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 CRISPR libraries market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 CRISPR-based gene editing market: Application outlook key takeaways
Fig. 27 CRISPR-based gene editing market: Application movement analysis
Fig. 28 Biomedical market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Therapeutic development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Genetic disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Ophthalmology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Ex vivo market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 In vivo market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Agricultural applications market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Plant engineering market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Farm animals engineering market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 CRISPR-based gene editing market: End use outlook key takeaways
Fig. 42 CRISPR-based gene editing market: End use movement analysis
Fig. 43 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Academic & research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Regional marketplace outlook, 2023 & 2030 (USD Million)
Fig. 47 Regional marketplace: Key takeaways
Fig. 48 North America CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 US CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Canada CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Mexico CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Europe CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 UK CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Germany CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 France CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Spain CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Italy CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Denmark CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Sweden CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Norway CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Asia Pacific CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Japan CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 China CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 India CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Australia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 South Korea CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Thailand CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Brazil CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Argentina CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 South Africa CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 UAE CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Kuwait CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Market participant categorization
Fig. 98 Company market position analysis, 2023
Fig. 99 Strategic framework

Companies Mentioned

The leading players in the CRISPR-based Gene Editing market include:
  • Revvity, Inc.
  • Danaher
  • GenScript
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Tocris Bioscience
  • OriGene Technologies, Inc.
  • Bio-Rad Laboratories
  • Bio-Techne
  • New England Biolabs, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 3.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.14 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service, By Application (Biomedical, Agricultural), By End-use (Biotechnology & Pharmaceutical Companies), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service, By Application (Biomedical, Agricultural), By End-use (Biotechnology & Pharmaceutical Companies), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 160 Pages
  • Global
From
Mutation Detection Kits In Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, TALENs/MegaTALs, ZFN, Meganucleases), by End-use, by Region, and Segment Forecasts, 2021-2028 - Product Image

Mutation Detection Kits In Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, TALENs/MegaTALs, ZFN, Meganucleases), by End-use, by Region, and Segment Forecasts, 2021-2028

  • Report
  • 100 Pages
  • Global
From
Global CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Forecast 2024-2030 - Product Image

Global CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type (Lentivirus), By Route Of Administration, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type (Lentivirus), By Route Of Administration, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
U.S. Gene Therapy Market Size, Share & Trends Analysis Report by Indication (Multiple Myeloma, Spinal Muscular Atrophy, Inherited Retinal Disease), Route Of Administration, Vector Type (Lentivirus, AAV, Adenovirus), and Segment Forecasts, 2024-2030 - Product Image

U.S. Gene Therapy Market Size, Share & Trends Analysis Report by Indication (Multiple Myeloma, Spinal Muscular Atrophy, Inherited Retinal Disease), Route Of Administration, Vector Type (Lentivirus, AAV, Adenovirus), and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • United States
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.